Home
/ Reactions / Product Use In Unapproved Indication
Product Use In Unapproved Indication
Drugs Associated with Product Use In Unapproved Indication
ADAPALENE
ARIPIPRAZOLE
ARIPIPRAZOLE ORAL
ARIPIPRAZOLE ORALLY DISINTEGRATING
AZITHROMYCIN
AZITHROMYCIN MONOHYDRATE
BUDESONIDE
CEFTRIAXONE
CEFTRIAXONE SODIUM
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE FOR INJECTION
CYCLOPHOSPHAMIDE INJECTION, SOLUTION
CYCLOSPORINE
CYTARABINE
DICLOFENAC SODIUM
DOXORUBICIN
DOXORUBICIN HYDROCHLORIDE
DUPILUMAB
ETOPOSIDE
FLUDARABINE PHOSPHATE
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE
IBUPROFEN SODIUM
IBUPROFEN TABLETS, COATED
METHYLPREDNISOLONE
MINOXIDIL
MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
MYCOPHENOLIC ACID
ORAL SEMAGLUTIDE
PALIPERIDONE PALMITATE
PEMBROLIZUMAB
POLYETHYLENE GLYCOL 3350
PREDNISOLONE
PREDNISOLONE ORAL
PREDNISOLONE ORAL SOLUTION
PROPRANOLOL HYDROCHLORIDE
RISPERIDONE
SALICYLIC ACID
SEMAGLUTIDE
TACROLIMUS
TACROLIMUS EXTENDED-RELEASE CAPSULES
TACROLIMUS OINTMENT 0.1%
TOPIRAMATE
TOPIRAMATE SPINKLE
TRIAMCINOLONE ACETONIDE
VALPROIC ACID
VINCRISTINE SULFATE
VORICONAZOLE
Disclaimer:
Based on FDA adverse event reports. Not medical advice. Adverse event reports do not prove causation.